Ohcanbohtosat - Nobuya Inagaki

Aiddostahte ozu
  1. 1
    Role of sodium‐glucose transporters in glucose uptake of the intestine and kidney

    Role of sodium‐glucose transporters in glucose uptake of the intestine and kidney Dahkki Norio Harada, Nobuya Inagaki

    Almmustuhtton 2012
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Renal sodium glucose cotransporter 2 inhibitors as a novel therapeutic approach to treatment of type 2 diabetes: Clinical data and mechanism of action

    Renal sodium glucose cotransporter 2 inhibitors as a novel therapeutic approach to treatment of type 2 diabetes: Clinical data and mechanism of action Dahkki Yoshihito Fujita, Nobuya Inagaki

    Almmustuhtton 2014
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Subunit stoichiometry of the pancreatic β‐cell ATP‐sensitive K<sup>+</sup> channel

    Subunit stoichiometry of the pancreatic β‐cell ATP‐sensitive K<sup>+</sup> channel Dahkki Nobuya Inagaki, Tohru Gonoi, Susumu Seino

    Almmustuhtton 1997
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    MgADP Antagonism to Mg2+-independent ATP Binding of the Sulfonylurea Receptor SUR1

    MgADP Antagonism to Mg2+-independent ATP Binding of the Sulfonylurea Receptor SUR1 Dahkki Kazumitsu Ueda, Nobuya Inagaki, Susumu Seino

    Almmustuhtton 1997
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    Non-invasive Beta-cell Imaging: Visualization, Quantification, and Beyond

    Non-invasive Beta-cell Imaging: Visualization, Quantification, and Beyond Dahkki Takaaki Murakami, Hiroyuki Fujimoto, Nobuya Inagaki

    Almmustuhtton 2021
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  6. 6
    Cellular Senescence in Diabetes Mellitus: Distinct Senotherapeutic Strategies for Adipose Tissue and Pancreatic β Cells

    Cellular Senescence in Diabetes Mellitus: Distinct Senotherapeutic Strategies for Adipose Tissue and Pancreatic β Cells Dahkki Takaaki Murakami, Nobuya Inagaki, Hiroshi Kondoh

    Almmustuhtton 2022
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  7. 7
    Role of Reactive Oxygen Species in Glucose Metabolism Disorder in Diabetic Pancreatic β-Cells

    Role of Reactive Oxygen Species in Glucose Metabolism Disorder in Diabetic Pancreatic β-Cells Dahkki Eri Mukai, Shimpei Fujimoto, Nobuya Inagaki

    Almmustuhtton 2022
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  8. 8
    Pharmacokinetics, Pharmacodynamics, and Safety of Canagliflozin in Japanese Patients with Type 2 Diabetes Mellitus

    Pharmacokinetics, Pharmacodynamics, and Safety of Canagliflozin in Japanese Patients with Type 2 Diabetes Mellitus Dahkki Hiroaki Iijima, Takayuki Kifuji, Nobuko Maruyama, Nobuya Inagaki

    Almmustuhtton 2015
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  9. 9
    Efficacy and safety of canagliflozin alone or as add‐on to other oral antihyperglycemic drugs in Japanese patients with type 2 diabetes: A 52‐week open‐label study

    Efficacy and safety of canagliflozin alone or as add‐on to other oral antihyperglycemic drugs in Japanese patients with type 2 diabetes: A 52‐week open‐label study Dahkki Nobuya Inagaki, Kazuoki Kondo, Toru Yoshinari, Hideki Kuki

    Almmustuhtton 2014
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  10. 10
    Characterization and Classification of ATP-binding Cassette Transporter ABCA3 Mutants in Fatal Surfactant Deficiency

    Characterization and Classification of ATP-binding Cassette Transporter ABCA3 Mutants in Fatal Surfactant Deficiency Dahkki Yoshihiro Matsumura, Nobuhiro Ban, Kazumitsu Ueda, Nobuya Inagaki

    Almmustuhtton 2006
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  11. 11
    <scp>iPSC</scp> technology‐based regenerative therapy for diabetes

    <scp>iPSC</scp> technology‐based regenerative therapy for diabetes Dahkki Yasushi Kondo, Tarō Toyoda, Nobuya Inagaki, Kenji Osafune

    Almmustuhtton 2017
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  12. 12
    c-Jun represses the human insulin promoter activity that depends on multiple cAMP response elements.

    c-Jun represses the human insulin promoter activity that depends on multiple cAMP response elements. Dahkki Nobuya Inagaki, Tomoko Maekawa, T Sudo, Shunsuke Ishii, Yutaka Seino, Hiroo Imura

    Almmustuhtton 1992
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  13. 13
    Synaptotagmin III is a novel isoform of rat synaptotagmin expressed in endocrine and neuronal cells.

    Synaptotagmin III is a novel isoform of rat synaptotagmin expressed in endocrine and neuronal cells. Dahkki Masanari Mizuta, Nobuya Inagaki, Y Nemoto, Shigeru Matsukura, Masayuki Takahashi, Susumu Seino

    Almmustuhtton 1994
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  14. 14
    Efficacy and safety of once‐weekly dulaglutide in combination with sulphonylurea and/or biguanide compared with once‐daily insulin glargine in <scp>J</scp>apanese patients with type 2 diabetes: a randomized, open‐label, phase <scp>III</scp>, non‐inferiority study

    Efficacy and safety of once‐weekly dulaglutide in combination with sulphonylurea and/or biguanide compared with once‐daily insulin glargine in <scp>J</scp>apanese patients with typ... Dahkki Eiichi Araki, Nobuya Inagaki, Yukio Tanizawa, Tomonori Oura, Masakazu Takeuchi, Takeshi Imaoka

    Almmustuhtton 2015
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  15. 15
    Measurement of Glucose Uptake and Intracellular Calcium Concentration in Single, Living Pancreatic β-Cells

    Measurement of Glucose Uptake and Intracellular Calcium Concentration in Single, Living Pancreatic β-Cells Dahkki Katsuya Yamada, Masanori Nakata, Naoki Horimoto, Mikako Saito, Hideaki Matsuoka, Nobuya Inagaki

    Almmustuhtton 2000
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  16. 16
    Efficacy and safety of canagliflozin in Japanese patients with type 2 diabetes: a randomized, double‐blind, placebo‐controlled, 12‐week study

    Efficacy and safety of canagliflozin in Japanese patients with type 2 diabetes: a randomized, double‐blind, placebo‐controlled, 12‐week study Dahkki Nobuya Inagaki, Kazuoki Kondo, Toru Yoshinari, Nobuko Maruyama, Yutaka Susuta, Hideki Kuki

    Almmustuhtton 2013
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  17. 17
    Cellular localization of synaptotagmin I, II, and III mRNAs in the central nervous system and pituitary and adrenal glands of the rat

    Cellular localization of synaptotagmin I, II, and III mRNAs in the central nervous system and pituitary and adrenal glands of the rat Dahkki Béatrice Marquèze‐Pouey, JA Boudier, Masanari Mizuta, Nobuya Inagaki, Susumu Seino, Michael Seagar

    Almmustuhtton 1995
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  18. 18
    Efficacy and safety of canagliflozin in combination with insulin: a double-blind, randomized, placebo-controlled study in Japanese patients with type 2 diabetes mellitus

    Efficacy and safety of canagliflozin in combination with insulin: a double-blind, randomized, placebo-controlled study in Japanese patients with type 2 diabetes mellitus Dahkki Nobuya Inagaki, Shin‐ichi Harashima, Nobuko Maruyama, Yutaka Kawaguchi, Maki Goda, Hiroaki Iijima

    Almmustuhtton 2016
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  19. 19
    Intra‐ and inter‐subject variability for increases in serum ketone bodies in patients with type 2 diabetes treated with the sodium glucose co‐transporter 2 inhibitor canagliflozin

    Intra‐ and inter‐subject variability for increases in serum ketone bodies in patients with type 2 diabetes treated with the sodium glucose co‐transporter 2 inhibitor canagliflozin... Dahkki David Polidori, Hiroaki Iijima, Maki Goda, Nobuko Maruyama, Nobuya Inagaki, Peter A. Crawford

    Almmustuhtton 2018
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  20. 20
    Disruption of TBP-2 ameliorates insulin sensitivity and secretion without affecting obesity

    Disruption of TBP-2 ameliorates insulin sensitivity and secretion without affecting obesity Dahkki Eiji Yoshihara, Shimpei Fujimoto, Nobuya Inagaki, Katsuya Okawa, So Masaki, Junji Yodoi, Hiroshi Masutani

    Almmustuhtton 2010
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: